Year: 2021

– Received Orphan Drug and Rare Pediatric Disease designations for DB-OTO for the treatment of otoferlin-related congenital hearing loss – – On track for key 2022 milestones including submission of IND and/or CTA for DB-OTO and interim analysis of DB-020 Phase 1b trial for cisplatin-induced hearing loss – – Announces AAV.104 gene therapy program for restoration of hearing in patients with congenital hearing impairment due to recessive mutations in the stereocilin gene – BOSTON, Nov. 10, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today reported financial results for the third quarter ended September 30, 2021 and provided a corporate update. “Decibel...

Lead program, CNTY-101 in relapsed/refractory non-Hodgkin’s lymphoma, remains on track for IND filing in mid-2022 Pre-clinical data from CNTY-101 program and CAR-iT platform to be presented at the ASH Annual Meeting Research and development update to be held on Thursday, December 16, 8:00-9:30 AM EST Made significant investment in building in-house manufacturing facility and new laboratory space Ended third quarter with cash, cash equivalents, and marketable securities of $400.3M PHILADELPHIA, Nov. 10, 2021 (GLOBE NEWSWIRE) — Century Therapeutics, Inc., (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today reported financial results and business highlights for the third quarter ended September 30, 2021. “We continue to deepen investments...

Financial HighlightsQ3 revenue up 15.1%; 14.5% in constant currency Q3 operating earnings of $9.0 million; up from a loss a year ago and up 25.9% on an adjusted basis Q3 earnings per share of $0.87 up from $0.42 a year ago; adjusted EPS of $0.25 compared to $0.29TROY, Mich., Nov. 10, 2021 (GLOBE NEWSWIRE) — Kelly® (Nasdaq: KELYA, KELYB), a leading specialty talent solutions provider, today announced results for the third quarter of 2021. Peter Quigley, president and chief executive officer, announced revenue for the third quarter of 2021 totaled $1.2 billion, a 15.1% increase compared to the corresponding quarter of 2020. Revenue improved year-over-year in the quarter reflecting increased customer demand compared to the COVID-19-impacted prior year period. Earnings from operations in the third quarter of 2021 totaled $9.0 million,...

Headset Canadian Insights Sales Data confirms Auxly as the #5 LP in terms of national market share with 7.3% of total sales Supporting further growth, the Company launches fall innovations including new products, seasonal flavors and new strains and formulations TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, today introduces a fall lineup packed with innovative new products, flavours and formulations designed to delight Canadian cannabis consumers. This new lineup is launching as the Company announces that it has achieved one of its key 2021 objectives by achieving the #5 position among Canadian Licensed Producers. Auxly continues to expand its market share in the Canadian cannabis sector...

Parsons Corporation Receives the 2021 Above and Beyond ESGR AwardCarey Smith and Parsons Corporation is once again recognized for their outstanding support to the veteran community.CENTREVILLE, Va., Nov. 10, 2021 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today the receipt of three individual awards recognizing its culture of support and empowerment to the military veteran community and its position as an excellent company for veteran employment. The awards received were:2021 Above and Beyond Award from the Virginia Committee of Department of Defense Employer Support of the Guard and Reserve (ESGR) #17 on the Military Times: Best for Vets 2021 GI Jobs: Military Friendly Employers 2022 Gold Ranking“We cannot do enough to thank those who’ve served our nation,” said Carey Smith,...

TORONTO, Nov. 10, 2021 (GLOBE NEWSWIRE) — Marathon Gold Corporation (“Marathon” or the “Company”; TSX: MOZ) today announces its financial results for the third quarter ending September 30, 2021 and provides an update on the Company’s activities at the Valentine Gold Project located in central Newfoundland (the “Project”). Third Quarter HighlightsAt September 30, 2021, the Company had cash and short term investments of $104.8 million, leaving it well positioned to execute on its permitting, development, and exploration activities at the Valentine Gold Project; At September 30, 2021, the Company had completed 54,507 metres of its total full-year drilling budget of approximately 70,000 metres. A total of 44,240 metres were drilled in the Berry Deposit, 3,639 metres in the Victory Deposit, 2,885 metres in the Sprite Deposit and 3,744...

Limestone expected to increase near term production throughput, and expand and automate its Tennessee boatbuilding facility to meet its growing backlog and increased demand for both its Limestone and Aquasport Brands through 2023 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. COLLINGWOOD, Ontario, Nov. 10, 2021 (GLOBE NEWSWIRE) — The Limestone Boat Company Limited (“Limestone” or the “Company”) (TSXV: BOAT) is pleased to announce a brokered private placement (the “Offering”), led by Beacon Securities Limited (“Beacon”) of up to 16.67 million units (the “Units”) at a price of $0.24 per Unit (the “Issue Price“), to raise gross proceeds of up to $4.0 million. The Offering will be carried out on a commercially reasonable best efforts basis to accredited investors...

Pipestone Development MapPipestone Development Map2022 Free Cash Flow Allocation2022 Free Cash Flow AllocationCALGARY, Alberta, Nov. 10, 2021 (GLOBE NEWSWIRE) — (PIPE – TSX) Pipestone Energy Corp. (“Pipestone” or the “Company”) is pleased to report its Q3 2021 financial and operational results, as well as provide an update on its operations. During Q3 2021, Pipestone delivered a third consecutive record quarter with respect to production, revenue, and cash flow, underpinned by the continued efficient execution of its organic development program. Commencing in Q4 2021, the Company expects to generate significant free cash flow, with forecast annual free cash flow of $140 – $160 million in 2022 and $230 million in 2023 (US$70 WTI | C$3.50 AECO). Pipestone’s first priority use for free cash...

VONORE, Tenn., Nov. 10, 2021 (GLOBE NEWSWIRE) — MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2022 first quarter ended October 3, 2021. Highlights:Delivered the most profitable first quarter in the Company’s history, with record unit sales, net sales, net income, and adjusted EBITDA. Net sales for the first quarter increased to $144.0 million, up 38.8%. Net income was $10.4 million or $0.55 per diluted share. Diluted Adjusted Net Income per share, a non-GAAP measure, was $0.67, up 15.5%. Adjusted EBITDA, a non-GAAP measure, increased to $19.4 million, up 14.3%. Initiated purchasing under the $50 million share repurchase program.Fred Brightbill, Chief Executive Officer and Chairman, commented, “Our business performed extremely well during the first quarter in a very challenging...

PLEASANTON, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) — Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the “Company”), a leading provider of cloud and data transformation solutions, today announced that Suresh Venkatachari, Chairman and CEO is scheduled to present virtually at the Credit Suisse 30th Annual Healthcare Conference on Thursday, November 11 at 1:50 pm ET. A replay of the event will be available on Healthcare Triangle’s investor relations website www.healthcaretriangle.com About Healthcare Triangle, Inc. (HCTI) Healthcare Triangle, Inc. based in Pleasanton, Calif., reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations—including hospitals and health systems and health plans—as well as pharma and life sciences organizations,...